Technical Analysis for ACAD - ACADIA Pharmaceuticals Inc.

Grade Last Price % Change Price Change
F 18.72 1.30% 0.24
ACAD closed up 1.3 percent on Monday, March 18, 2024, on 1.16 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
5 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction 1.30%
NR7 Range Contraction 1.30%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 8 hours ago
Possible NR7 about 8 hours ago
Up 1% about 9 hours ago
Fell Below Previous Day's Low about 12 hours ago
Rose Above Lower Bollinger Band about 13 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ACADIA Pharmaceuticals Inc. Description

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by pimavanserin, which is in Phase III development stage for the treatment of Parkinson's disease psychosis. It is also developing pimavanserin that has completed Phase II co-therapy trials for the treatment of schizophrenia; and is in Phase II clinical trials for the treatment of Alzheimer's disease psychosis. In addition, the company, through collaboration with Allergan, Inc., is developing alpha adrenergic agonists, which are in Phase II clinical trials for the treatment of chronic pain; and muscarinic agonist that is in Phase I clinical trials for the treatment of glaucoma. Further, it is developing two advanced preclinical programs directed at Parkinson's disease and other neurological disorders. The company was formerly known as Receptor Technologies, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Alzheimer's Disease Chemical Compounds Parkinson's Disease Schizophrenia Chronic Pain Neurological Disorders Central Nervous System Disorders Nervous System Disorders Glaucoma Urological Disorders Treatment Of Parkinson's Disease Treatment Of Chronic Pain Treatment Of Glaucoma Psychosis Treatment Of Alzheimer's Disease Treatment Of Schizophrenia

Is ACAD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 33.9069
52 Week Low 17.71
Average Volume 1,894,692
200-Day Moving Average 25.45
50-Day Moving Average 25.50
20-Day Moving Average 23.00
10-Day Moving Average 21.36
Average True Range 1.22
RSI (14) 25.37
ADX 36.26
+DI 7.47
-DI 37.82
Chandelier Exit (Long, 3 ATRs) 22.90
Chandelier Exit (Short, 3 ATRs) 21.82
Upper Bollinger Bands 27.81
Lower Bollinger Band 18.18
Percent B (%b) 0.06
BandWidth 41.85
MACD Line -1.80
MACD Signal Line -1.28
MACD Histogram -0.5153
Fundamentals Value
Market Cap 3.07 Billion
Num Shares 164 Million
EPS -0.91
Price-to-Earnings (P/E) Ratio -20.57
Price-to-Sales 6.85
Price-to-Book 11.94
PEG Ratio -0.42
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.64
Resistance 3 (R3) 19.55 19.16 19.48
Resistance 2 (R2) 19.16 18.93 19.20 19.43
Resistance 1 (R1) 18.94 18.78 19.05 19.03 19.38
Pivot Point 18.55 18.55 18.61 18.59 18.55
Support 1 (S1) 18.33 18.32 18.44 18.42 18.06
Support 2 (S2) 17.94 18.17 17.98 18.01
Support 3 (S3) 17.72 17.94 17.96
Support 4 (S4) 17.81